[GetPortalCommentsPageByObjectIdResponse(id=2277878, encodeId=a52022e78789d, content=抱着试试看的心态都投的,8月16号投的,3天后就由Awaiting Reviewer Selection变成了awaiting decision了,等着被拒了。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Aug 19 16:16:04 CST 2025, time=2025-08-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2264205, encodeId=71f7226420590, content=请问各位前辈们,摘要被录取意味着什么?是不是值得开心的事?后续投全文被录取的概率会变大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3059148737, createdName=ms5000000551965577, createdTime=Fri May 09 15:30:51 CST 2025, time=2025-05-09, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2242077, encodeId=b5e022420e799, content=各位大佬,咨询个事情,最近有投稿遇到点提交时一直显示无法提交的情况吗?按要求都完善了资料但是提交后没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03119567936, createdName=ms4000000550603683, createdTime=Thu Dec 12 17:50:14 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
[GetPortalCommentsPageByObjectIdResponse(id=2277878, encodeId=a52022e78789d, content=抱着试试看的心态都投的,8月16号投的,3天后就由Awaiting Reviewer Selection变成了awaiting decision了,等着被拒了。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Aug 19 16:16:04 CST 2025, time=2025-08-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2264205, encodeId=71f7226420590, content=请问各位前辈们,摘要被录取意味着什么?是不是值得开心的事?后续投全文被录取的概率会变大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3059148737, createdName=ms5000000551965577, createdTime=Fri May 09 15:30:51 CST 2025, time=2025-05-09, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2242077, encodeId=b5e022420e799, content=各位大佬,咨询个事情,最近有投稿遇到点提交时一直显示无法提交的情况吗?按要求都完善了资料但是提交后没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03119567936, createdName=ms4000000550603683, createdTime=Thu Dec 12 17:50:14 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
[GetPortalCommentsPageByObjectIdResponse(id=2277878, encodeId=a52022e78789d, content=抱着试试看的心态都投的,8月16号投的,3天后就由Awaiting Reviewer Selection变成了awaiting decision了,等着被拒了。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Aug 19 16:16:04 CST 2025, time=2025-08-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2264205, encodeId=71f7226420590, content=请问各位前辈们,摘要被录取意味着什么?是不是值得开心的事?后续投全文被录取的概率会变大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3059148737, createdName=ms5000000551965577, createdTime=Fri May 09 15:30:51 CST 2025, time=2025-05-09, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2242077, encodeId=b5e022420e799, content=各位大佬,咨询个事情,最近有投稿遇到点提交时一直显示无法提交的情况吗?按要求都完善了资料但是提交后没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03119567936, createdName=ms4000000550603683, createdTime=Thu Dec 12 17:50:14 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
[GetPortalCommentsPageByObjectIdResponse(id=2277878, encodeId=a52022e78789d, content=抱着试试看的心态都投的,8月16号投的,3天后就由Awaiting Reviewer Selection变成了awaiting decision了,等着被拒了。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Aug 19 16:16:04 CST 2025, time=2025-08-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2264205, encodeId=71f7226420590, content=请问各位前辈们,摘要被录取意味着什么?是不是值得开心的事?后续投全文被录取的概率会变大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3059148737, createdName=ms5000000551965577, createdTime=Fri May 09 15:30:51 CST 2025, time=2025-05-09, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2242077, encodeId=b5e022420e799, content=各位大佬,咨询个事情,最近有投稿遇到点提交时一直显示无法提交的情况吗?按要求都完善了资料但是提交后没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03119567936, createdName=ms4000000550603683, createdTime=Thu Dec 12 17:50:14 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.
* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done * "What this study adds" - summarise what we now know as a result of this study that we did not know before * "How this study might affect research, practice or policy" - summarise the implications of this study
This will be published as a summary box after the abstract in the final published. ”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗
[GetPortalCommentsPageByObjectIdResponse(id=2277878, encodeId=a52022e78789d, content=抱着试试看的心态都投的,8月16号投的,3天后就由Awaiting Reviewer Selection变成了awaiting decision了,等着被拒了。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Aug 19 16:16:04 CST 2025, time=2025-08-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2264205, encodeId=71f7226420590, content=请问各位前辈们,摘要被录取意味着什么?是不是值得开心的事?后续投全文被录取的概率会变大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3059148737, createdName=ms5000000551965577, createdTime=Fri May 09 15:30:51 CST 2025, time=2025-05-09, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2242077, encodeId=b5e022420e799, content=各位大佬,咨询个事情,最近有投稿遇到点提交时一直显示无法提交的情况吗?按要求都完善了资料但是提交后没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03119567936, createdName=ms4000000550603683, createdTime=Thu Dec 12 17:50:14 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
[GetPortalCommentsPageByObjectIdResponse(id=2277878, encodeId=a52022e78789d, content=抱着试试看的心态都投的,8月16号投的,3天后就由Awaiting Reviewer Selection变成了awaiting decision了,等着被拒了。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Aug 19 16:16:04 CST 2025, time=2025-08-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2264205, encodeId=71f7226420590, content=请问各位前辈们,摘要被录取意味着什么?是不是值得开心的事?后续投全文被录取的概率会变大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3059148737, createdName=ms5000000551965577, createdTime=Fri May 09 15:30:51 CST 2025, time=2025-05-09, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2242077, encodeId=b5e022420e799, content=各位大佬,咨询个事情,最近有投稿遇到点提交时一直显示无法提交的情况吗?按要求都完善了资料但是提交后没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03119567936, createdName=ms4000000550603683, createdTime=Thu Dec 12 17:50:14 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
[GetPortalCommentsPageByObjectIdResponse(id=2277878, encodeId=a52022e78789d, content=抱着试试看的心态都投的,8月16号投的,3天后就由Awaiting Reviewer Selection变成了awaiting decision了,等着被拒了。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Aug 19 16:16:04 CST 2025, time=2025-08-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2264205, encodeId=71f7226420590, content=请问各位前辈们,摘要被录取意味着什么?是不是值得开心的事?后续投全文被录取的概率会变大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3059148737, createdName=ms5000000551965577, createdTime=Fri May 09 15:30:51 CST 2025, time=2025-05-09, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2242077, encodeId=b5e022420e799, content=各位大佬,咨询个事情,最近有投稿遇到点提交时一直显示无法提交的情况吗?按要求都完善了资料但是提交后没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03119567936, createdName=ms4000000550603683, createdTime=Thu Dec 12 17:50:14 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
[GetPortalCommentsPageByObjectIdResponse(id=2277878, encodeId=a52022e78789d, content=抱着试试看的心态都投的,8月16号投的,3天后就由Awaiting Reviewer Selection变成了awaiting decision了,等着被拒了。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Aug 19 16:16:04 CST 2025, time=2025-08-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2264205, encodeId=71f7226420590, content=请问各位前辈们,摘要被录取意味着什么?是不是值得开心的事?后续投全文被录取的概率会变大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3059148737, createdName=ms5000000551965577, createdTime=Fri May 09 15:30:51 CST 2025, time=2025-05-09, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2242077, encodeId=b5e022420e799, content=各位大佬,咨询个事情,最近有投稿遇到点提交时一直显示无法提交的情况吗?按要求都完善了资料但是提交后没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03119567936, createdName=ms4000000550603683, createdTime=Thu Dec 12 17:50:14 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
[GetPortalCommentsPageByObjectIdResponse(id=2277878, encodeId=a52022e78789d, content=抱着试试看的心态都投的,8月16号投的,3天后就由Awaiting Reviewer Selection变成了awaiting decision了,等着被拒了。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Aug 19 16:16:04 CST 2025, time=2025-08-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2264205, encodeId=71f7226420590, content=请问各位前辈们,摘要被录取意味着什么?是不是值得开心的事?后续投全文被录取的概率会变大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3059148737, createdName=ms5000000551965577, createdTime=Fri May 09 15:30:51 CST 2025, time=2025-05-09, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2242077, encodeId=b5e022420e799, content=各位大佬,咨询个事情,最近有投稿遇到点提交时一直显示无法提交的情况吗?按要求都完善了资料但是提交后没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03119567936, createdName=ms4000000550603683, createdTime=Thu Dec 12 17:50:14 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向:消化 经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro
[GetPortalCommentsPageByObjectIdResponse(id=2277878, encodeId=a52022e78789d, content=抱着试试看的心态都投的,8月16号投的,3天后就由Awaiting Reviewer Selection变成了awaiting decision了,等着被拒了。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/eccf35eff026d776b97c650c7e9da159.jpg, createdBy=4ba62196925, createdName=120a6ac7m01(暂无昵称), createdTime=Tue Aug 19 16:16:04 CST 2025, time=2025-08-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2264205, encodeId=71f7226420590, content=请问各位前辈们,摘要被录取意味着什么?是不是值得开心的事?后续投全文被录取的概率会变大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3059148737, createdName=ms5000000551965577, createdTime=Fri May 09 15:30:51 CST 2025, time=2025-05-09, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2242077, encodeId=b5e022420e799, content=各位大佬,咨询个事情,最近有投稿遇到点提交时一直显示无法提交的情况吗?按要求都完善了资料但是提交后没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03119567936, createdName=ms4000000550603683, createdTime=Thu Dec 12 17:50:14 CST 2024, time=2024-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2233813, encodeId=3e822233813ca, content=大佬们,我投了好几次了,每次都给我说“1. Summary Box<br><br>Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.<br><br>* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done<br>* "What this study adds" - summarise what we now know as a result of this study that we did not know before<br>* "How this study might affect research, practice or policy" - summarise the implications of this study<br><br>This will be published as a summary box after the abstract in the final published. <br>”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8492816, createdName=ms8000001567143208, createdTime=Tue Oct 29 07:50:40 CST 2024, time=2024-10-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2229665, encodeId=f8aa2229665d2, content=http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Mon Oct 07 16:08:12 CST 2024, time=2024-10-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2215335, encodeId=a0a1221533500, content=有人投过letter的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=ywh, createdTime=Tue Jul 16 23:19:30 CST 2024, time=2024-07-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217144, encodeId=533e221e14484, content=可以投case吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57c5578650, createdName=bush, createdTime=Sun Jul 28 00:35:59 CST 2024, time=2024-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1000690, encodeId=e40f100069031, content=偏重的研究方向: 消化 ; 胃肠病学 <br>经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=1484bf18m20暂无昵称, createdTime=Sun Jul 18 21:52:21 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149094, encodeId=3fb6214909480, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向:消化<br>经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri Jul 21 06:25:54 CST 2023, time=2023-07-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=926458, encodeId=7b4992645850, content=中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Mon Feb 22 21:01:44 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
抱着试试看的心态都投的,8月16号投的,3天后就由Awaiting Reviewer Selection变成了awaiting decision了,等着被拒了。
80 举报
请问各位前辈们,摘要被录取意味着什么?是不是值得开心的事?后续投全文被录取的概率会变大吗?
87 举报
各位大佬,咨询个事情,最近有投稿遇到点提交时一直显示无法提交的情况吗?按要求都完善了资料但是提交后没有任何反应。
121 举报
大佬们,我投了好几次了,每次都给我说“1. Summary Box
Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.
* "What is already known on this topic" - summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done
* "What this study adds" - summarise what we now know as a result of this study that we did not know before
* "How this study might affect research, practice or policy" - summarise the implications of this study
This will be published as a summary box after the abstract in the final published.
”我改了好几次了还是给我发这个,但是这次好像没给我退回来,你们也是这样吗
140 举报
http://whereismypaper.bmj.com,可以查bmj旗下所有杂志投稿的审稿时间记录。请叫我雷锋
190 举报
有人投过letter的吗?
177 举报
可以投case吗?
185 举报
偏重的研究方向: 消化 ; 胃肠病学
经验分享:中了一篇letter,没有原始数据。投稿后当天晚上awaiting AE assigment,第二天awaiting reviewer selection,第三天晚上8点多decision in process,次日早上minor revision。基本是见过审letter最快的杂志之一了
396 举报
审稿速度:2.0 | 投稿命中率:5.0
偏重的研究方向:消化
经验分享:投稿两个月,awaiting decision两天,主编让transfer到其非sci的子刊,全程无审稿意见,两个月白等了,不像其官网说的审稿迅速。Thank you for choosing to submit your article to Gut. We have considered your article carefully and feel it is not quite right for Gut at this time. We therefore propose you consider transferring your submission to an alternative BMJ journal. Frontline Gastro
259 举报
中了1篇,稿件处理效率高,感觉对国人比较友好,看重创新性,同时也要兼顾证据的全面性和潜在临床价值
379 举报